My Winding Road: From Microbiology to Toxicology and Environmental Health

Abstract

I would certainly never have predicted that I would become the director of the National Institute of Environmental Health Sciences (NIEHS) and the National Toxicology Program (NTP) when I was a Jewish girl growing up in Teaneck, New Jersey. My family stressed the importance of education. Yet for a girl there were many not-so-subtle suggestions that the appropriate careers were in teaching or nursing, and the most important thing was to be a wife and mother. Well, I can't disagree with the latter, although I would have to add grandmother to that list of achievements. My parents were both college graduates, but my mom only taught high school English for one year before leaving the field to start our family. My dad returned from World War II and joined his brother in accounting. After my first sister was born, my father joined my mother's family jewelry business and helped to open a second retail store. My mother helped my dad out during the busy times—Christmas and wedding season—but otherwise focused on our growing family of three girls and one boy. This became increasingly challenging when it became clear that my little brother was severely retarded and would require extra care.

Embryonic vascular disruption adverse outcomes: Linking high throughput signaling signatures with functional consequences

“…Development of high-throughput screening (HTS) and in vitro profiling assays in recent years has generated advances towards providing the experimental throughput, target specificity, and computational capabilities necessary to thoroughly investigate vascular developmental toxicity. For example, the US EPA's ToxCast program and the Tox21 consortium generate in vitro HTS data on 1000's of chemicals against 100's of molecular targets and biological pathways [12] [13]. These HTS data facilitate chemical hazard identification to support chemical prioritization efforts for further evaluation under existing regulatory requirements (e.g.…”

New paradigms in GPCR drug discovery

“…Recent exhaustive and comprehensive studies of drug molecules and their diverse interactions demonstrated that target diversity is common for approved drugs, and some of the unanticipated pathways detected through modeling and broad screening could affect drug action [114,115]. The discovery of new targets for existing GPCR drugs could lead to drug repurposing, a current area of concentration for NIH [116]. The binding of a series of sterically constrained nucleosides at various GPCRs, as determined empirically, was analyzed showing consistent structural association [35], which can now be used to modify the ligands to augment or diminish polypharmacology.…”

How Did I Ever Get Here? The 2018 Mildred S. Christian Award Winner

“…I’ve been asked to share some brief thoughts about my career of over 40 years. I have recently written an invited autobiography by Annual Reviews of Pharmacology and Toxicology, “My Winding Road: From Microbiology to Toxicology and Environmental Health.” 1 It’s a pretty detailed tale of how my life, and career, has developed. It also addressed many of the questions that I’ve been asked to address, starting with how I got started in science, the challenges I’ve faced, and to what I really think is most important to be successful in science.…”